# Gadolinium \(III\) acetate hydrate — Safety Data Sheet — ProChem

原本PDFから抽出したテキストです。表、画像、記号、OCR結果は原本と異なる場合があります。安全情報は原本PDFで確認してください。

- **文書名:** Gadolinium \(III\) acetate hydrate — Safety Data Sheet — ProChem
- **発行元:** ProChem
- **材料:** Gadolinium \(III\) acetate hydrate
- **CAS番号:** 100587\-93\-7
- **製品番号・グレード:** 1808
- **文書種類:** SDS
- **原文の言語:** English
- **地域:** 
- **改訂日:** 
- **ページ数:** 4
- **原本ファイル名:** 090\_Gadolinium\_III\_acetate\_hydrate\_ProChem\_EN\.pdf
- **RESDSページ:** https://resds\.com/document/gadolinium\-iii\-acetate\-hydrate\-sds\-en\-95b5b94b6f
- **原本PDF:** https://resds\.com/pdf/gadolinium\-iii\-acetate\-hydrate\-sds\-en\-95b5b94b6f\.pdf
- **情報源URL:** https://prochemonline\.com/wp\-content/uploads/2024/09/1808\.GadoliniumAcetateHydrate\.pdf
- **説明:** Original ProChem safety data sheet for Gadolinium \(III\) acetate hydrate\. Original PDF retained without modification\. Source collected on 2026\-09\-13\.

## ページ 1

```text
 SECTION 1     PRODUCT AND COMPANY INFORMATION

PRODUCT NAME:    Gadolinium (III) acetate hydrate

PRODUCT NUMBER:  1808

CAS NUMBER:       100587-93-7


MANUFACTURER:


Prochem, Inc.                                        PHONE:        815-398-1788
826 Roosevelt Road                                          FAX:           815-398-1810
Rockford, IL  61109                                    TOLL FREE:    800-795-8788

                   IN CASE OF TRANSPORTATION EMERGENCY CONTACT CHEM-TREC: 1-800-424-9300

SECTION 2    HAZARDS IDENTIFICATION

CLASSIFICATION OF SUBSTANCE OR MIXTURE



Pictogram


Signal Word         Warning

Hazard Statements

 H315              Causes skin irritation.
 H319              Causes serious eye irritation.
 H335             May cause respiratory irritation.

Precautionary Phrases

 P261                Avoid breathing dust/fume/gas/mist/vapour/spray.
 P305+P351+P338     IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy
                           to do. Continue rinsing.


HMIS CLASSIFICATION:
Health: 2            Flammability: 0                  Reactivity: 0
NFPA RATING:
Health: 2              Fire: 0                           Reactivity Hazard: 0

EYE CONTACT: Causes irritation of the eyes.
SKIN CONTACT: Causes irritation of the skin.
INHALATION: Causes irritation to nose, throat, and respiratory tract.
INGESTION: May be harmful if swallowed.


GADOLINIUM ACETATE HYDRATE                                                                 PAGE 1
```

## ページ 2

```text
SECTION 3      COMPOSITION / INFORMATION ON INGREDIENTS

Formula: Gd(OOCCH3)3! XH2O

Molecular Weight: 334.39 (anhy.)


CHEMICAL NAME                                           CAS#                               %


Gadolinium (III) acetate hydrate                                           100587-93-7                                             100

SECTION 4   FIRST AID MEASURES

EYE EXPOSURE: Immediately flush the eyes with copious amounts of water (lukewarm if possible). Assure flushing under
eyelids. A victim may need assistance in keeping their eyelids open. Get immediate competent medical attention.
SKIN EXPOSURE: Wash affected area with soap and water. Remove contaminated clothes if necessary. Seek medical
assistance if irritation persists.
INHALATION: Remove victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in
breathing, coughing, wheezing, or pain. In such cases, seek immediate medical assistance. Give oxygen if deemed
necessary.  If not breathing administer CPR. Get emergency care immediately.
INGESTION: Keep the victim calm. Seek medical assistance immediately.

SECTION 5   FIREFIGHTING MEASURES

FLASH POINT: Not applicable
AUTO IGNITION TEMPERATURE: Not applicable
EXPLOSION LIMITS: No data
EXTINGUISHING MEDIUM: Water spray or carbon dioxide.
SPECIAL FIRE FIGHTING PROCEDURES: If involved in a fire, fire fighters should be equipped with a NIOSH approved
positive self-contained breathing apparatus, flame and chemical resistant clothing, hats, boots, and gloves.
HAZARDOUS COMBUSTION AND DECOMPOSITION PRODUCTS: Carbon monoxide, carbon dioxide, and gadolinium
oxide.

SECTION 6   ACCIDENTAL RELEASE MEASURES

PERSONAL PRECAUTIONS: Wear approved personal protective equipment. Avoid dust formation. Avoid breathing dust, vapors, mist
or gas. Ensure adequate ventilation.
ENVIRONMENTAL PRECAUTIONS: Do not let product enter drains or allow to be released into the environment.
METHODS AND MATERIALS FOR CONTAINMENT AND CLEANING UP: Wear appropriate respiratory and protective equipment to
avoid exposure with material, sweep up avoiding raising dust and place in a well-marked container for disposal.

SECTION 7   HANDLING AND STORAGE

PRECAUTIONS FOR SAFE HANDLING: Avoid contact with skin and eyes. Avoid formation of dust. Provide appropriate exhaust
ventilation.
CONDITIONS FOR SAFE STORAGE: Hygroscopic. Picks up moisture readily from air. Keep from humidity and water. Store in a
tightly sealed container. Keep in a dry area. Store away from oxidizing agents.

SECTION 8  EXPOSURE CONTROLS AND PERSONAL PROTECTION

EYE PROTECTION: Always wear approved safety glasses with side shields, safety goggles, or face shield when handling a chemical
substance in the laboratory.
SKIN PROTECTION: Chemical resistant gloves.
VENTILATION: Handle in an efficient chemical fume hood.
RESPIRATOR:  If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators requires a
Respirator Protection Program to be in compliance with 29 CFR 19-10.134.

SECTION 9 PHYSICAL AND CHEMICAL PROPERTIES

COLOR AND FORM: White crystalline solid
MOLECULAR WEIGHT: 334.39 (anhy.)
BOILING POINT: No data available


 GADOLINIUM ACETATE HYDRATE                                                                 PAGE 2
```

## ページ 3

```text
SECTION 9 PHYSICAL AND CHEMICAL PROPERTIES (Cont.)

MELTING POINT: No data available
SPECIFIC GRAVITY: 1.611 gm/ml
ODOR: Odorless
VAPOR PRESSURE: Not applicable
SOLUBILITY: Slightly soluble

SECTION 10  STABILITY AND REACTIVITY

STABILITY: Stable
HAZARDOUS POLYMERIZATION: Will not occur
CONDITIONS TO AVOID: Humidity and moisture (hygroscopic)
INCOMPATIBILITY: Strong oxidizing agents, water, and moisture
DECOMPOSITION PRODUCTS: Carbon monoxide, carbon dioxide, and gadolinium oxides


SECTION 11 TOXICOLOGICAL DATA

CARCINOGENIC EFFECTS: No components of this product present at levels greater than or equal to 0.1% is identified as a confirmed
carcinogen by IARC, ACGIH, NTP, and OSHA.
MUTAGENIC EFFECTS: Not available
TETRATOGENIC EFFECTS: Not available

To the best of our knowledge the toxicological effects of this compound have not been fully investigated.

SECTION 12  ECOLOGICAL DATA

No information available

SECTION 13  DISPOSAL CONSIDERATIONS

Dispose of in according to local, state, and federal regulations.

SECTION 14  TRANSPORTATION DATA

Non-hazardous material


SECTION 15  REGULATORY INFORMATION

TSCA: Not listed in the TSCA inventory
SARA 313 COMPONENTS: This material does not contain any chemical components with know CAS numbers that exceed the
threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 302 COMPONENTS: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 311/312 HAZARDS: Acute Health Hazard
MASSACHUSETTS RIGHT TO KNOW COMPONENTS: No components are subject to the Massachusetts Right To Know Act.
PENNSYLVANIA RIGHT TO KNOW COMPONENTS: Gadolinium (III) acetate hydrate
NEW JERSEY RIGHT TO KNOW COMPONENTS: Gadolinium (III) acetate hydrate
CALIFORNIA PROP. 65 COMPONENTS: This product does not contain any chemicals known to State of California to cause cancer,
birth defects, or any other reproductive harm.





 GADOLINIUM ACETATE HYDRATE                                                                 PAGE 3
```

## ページ 4

```text
SECTION 16  OTHER INFORMATION

DISCLAIMER: The information herein is believed to be accurate and reliable as of the date compiled. However, Prochem, Inc. makes
no representation, warranty, or guarantee of any kind with respect to the information in this document or any use of the product based
on the information.
DATE PREPARED: 05/14





 GADOLINIUM ACETATE HYDRATE                                                                 PAGE 4
```
